Records containing: Hemophilia A, Severe

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2026-07-02
  A Phase 3b Open-label Study Evaluating Physical Activity and Joint Health in Previously Treated Patients ≥12 Years With Severe Haemophilia A Treated With Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein (Efanesoctocog Alfa) for 24 Months
• CLINICAL_TRIALS study record update · 2026-02-17
  Hemophilia A Research Program (HARP): An Observational Intergenerational Cohort Study of Hemophilia A and Factor VIII Immunogenicity
• CLINICAL_TRIALS study record update · 2025-10-09
  A Phase 3b Open-label Study Evaluating Physical Activity and Joint Health in Previously Treated Patients ≥12 Years With Severe Haemophilia A Treated With Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein (Efanesoctocog Alfa) for 24 Months
• CLINICAL_TRIALS study record update · 2024-12-20
  Liver Biopsy In Haemophilia Gene Therapy
• CLINICAL_TRIALS study record update · 2024-12-18
  A Phase 1/3, Open-label, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Human Plasma-derived Factor VIII (SKP-0141) for the Treatment and Prophylaxis in Male Patients with Severe Hemophilia a
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2024-03-20
  Pharmacokinetic-guided Dosing of Emicizumab in Congenital Haemophilia A Patients - The DosEmi Study
• CLINICAL_TRIALS study record update · 2023-06-05
  The Validity and Reliability of the Turkish Version of the "Pediatric Haemophilia Activities List - Short - PedHALshort" Questionnaire
• CLINICAL_TRIALS study record update · 2021-02-15
  The Effect of Exercise Training on Pain, Physical Activity and Quality of Life in Pediatric Hemophilia Patients